Aytu Biopharma (AYTU) Non-Current Assets (2011 - 2026)
Aytu Biopharma's Non-Current Assets came in at $43.25 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 3.9% from $45 million a year earlier and down 2.5% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Non-Current Assets (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, Aytu Biopharma's Non-Current Assets data covers 57 quarters.
- Non-Current Assets has declined in each of the last five fiscal years, with a five-year compound annual growth rate of -23.1% (FY2021 to FY2026).
- Going back by fiscal year, Non-Current Assets was $45 million in FY2025 (-19.9%), $56.2 million in FY2024 (-14.0%), $65.38 million in FY2023 (-15.8%) and $77.69 million in FY2022 (-51.6%).
- The fiscal Q4 2026 figure represents the lowest quarterly Non-Current Assets since fiscal Q1 2020.
- Year-over-year, Non-Current Assets has declined for 18 consecutive quarters, with an average decline of 13.2% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in fiscal Q2 2022 (growth of 83.7%), and the weakest in fiscal Q4 2022 (a decline of 51.6%).
- Business Quant data shows AYTU's Non-Current Assets at $44.36 million (Q3 2026), $45.76 million (Q2 2026) and $43.88 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 43.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.25 Mn |
| Mar 31, 2026 | 44.36 Mn |
| Dec 31, 2025 | 45.76 Mn |
| Sep 30, 2025 | 43.88 Mn |
| Jun 30, 2025 | 45.00 Mn |
| Mar 31, 2025 | 51.69 Mn |
| Dec 31, 2024 | 53.17 Mn |
| Sep 30, 2024 | 55.09 Mn |
| Jun 30, 2024 | 56.20 Mn |
| Mar 31, 2024 | 57.73 Mn |
| Dec 31, 2023 | 59.88 Mn |
| Sep 30, 2023 | 62.29 Mn |
| Jun 30, 2023 | 65.38 Mn |
| Mar 31, 2023 | 68.75 Mn |
| Dec 31, 2022 | 70.83 Mn |
| Sep 30, 2022 | 75.59 Mn |
| Jun 30, 2022 | 77.69 Mn |
| Mar 31, 2022 | 90.88 Mn |
| Dec 31, 2021 | 136.28 Mn |
| Sep 30, 2021 | 138.69 Mn |
API Access
Aytu Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();